首页> Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology> Protein Kinase C β: a New Target Therapy to Prevent the Long-Term Atypical Antipsychotic-Induced Weight Gain.

Protein Kinase C β: a New Target Therapy to Prevent the Long-Term Atypical Antipsychotic-Induced Weight Gain.

导出 OA

翻译打印收藏纠错

第一作者： Alessandro,Rimessi

第一单位： Department of Morphology, Surgery and Experimental Medicine, Section of Pathology, Oncology and Experimental Biology, Laboratory for Technologies of Advanced Therapies (LTTA), University of Ferrara, Ferrara, Italy.

作者： Alessandro,Rimessi ^[1] ; Chiara,Pavan ^[2] ; Elli,Ioannidi ^[1] ; Federica,Nigro ^[1] ; Claudia,Morganti ^[1] ; Alberto,Brugnoli ^[3] ; Francesco,Longo ^[3] ; Chiara,Gardin ^[4] ; Letizia,Ferroni ^[4] ; Michele,Morari ^[3] ; Vincenzo,Vindigni ^[5] ; Barbara,Zavan ^[4] ; Paolo,Pinton ^[1]

作者单位： Department of Morphology, Surgery and Experimental Medicine, Section of Pathology, Oncology and Experimental Biology, Laboratory for Technologies of Advanced Therapies (LTTA), University of Ferrara, Ferrara, Italy. ^[1] Unit of Psychiatry, Department of Neurosciences NPSRR, University of Padua, Padua, Italy. ^[2] Department of Medical Sciences, Section of Pharmacology, Neuroscience Center and National Institute of Neuroscience, University of Ferrara, Ferrara, Italy. ^[3] Department of Biomedical Sciences, University of Padua, Padua, Italy. ^[4] Unit of Plastic Surgery, Department of Neurosciences NPSRR, University of Padua, Padua, Italy. ^[5]